Strategic Partnerships for Drug Discovery
Dassault Systèmes’ BIOVIA Contract Research partners with pharma and biotech industry to deliver novel, de-risked drug candidates that are optimized for success across a broad range of pharmacological and practical considerations. BIOVIA Contract Research team accomplishes this goal by creating virtual twins that combine state-of-the-art physics-based modeling and simulation methods with artificial intelligence/machine learning (AI/ML) models.
Read the use cases to learn how BIOVIA Contract Research supports pharma and biotech companies through various drug discovery and development challenges.